BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1400827)

  • 1. 32P-postlabelling and mass spectrometric methods for analysis of bulky, polyaromatic carcinogen-DNA adducts in humans.
    Talaska G; Roh JH; Getek T
    J Chromatogr; 1992 Sep; 580(1-2):293-323. PubMed ID: 1400827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined micropreparative techniques with synchronous fluorescence spectroscopy or 32P-postlabelling assay for carcinogen-DNA adduct determination.
    Shields PG; Kato S; Bowman ED; Petruzzelli S; Cooper DP; Povey AC; Weston A
    IARC Sci Publ; 1993; (124):243-54. PubMed ID: 8225491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection and characterization of carcinogen-DNA adducts in exfoliated urothelial cells from 4-aminobiphenyl-treated dogs by 32P-postlabelling and subsequent thin-layer and high-pressure liquid chromatography.
    Talaska G; Dooley KL; Kadlubar FF
    Carcinogenesis; 1990 Apr; 11(4):639-46. PubMed ID: 2323002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvements in the 32P-postlabelling procedure to quantify bulky aromatic DNA adducts.
    Steenwinkel MJ; Roggeband R; van Delft JH; Baan RA
    IARC Sci Publ; 1993; (124):65-70. PubMed ID: 7693587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of polycyclic aromatic hydrocarbon-DNA adducts by postlabelling with the weak beta-emitters 35S-phosphorothioate and 33P-phosphate, immobilized boronate chromatography and high-performance liquid chromatography.
    Baird WM; Lau HH; Schmerold I; Coffing SL; Brozich SL; Lee H; Harvey RG
    IARC Sci Publ; 1993; (124):217-26. PubMed ID: 8225488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 32P-postlabelling analysis of small aromatic and of bulky non-aromatic DNA adducts.
    Reddy MV
    IARC Sci Publ; 1993; (124):25-34. PubMed ID: 8225492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical (postlabelling) methods for analysis of carcinogen-DNA adducts.
    Randerath K; Randerath E; Agrawal HP; Reddy MV
    IARC Sci Publ; 1984; (59):217-31. PubMed ID: 6443609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-performance liquid chromatographic analysis of 32P-postlabeled DNA-aromatic carcinogen adducts.
    Levy GN; Weber WW
    Anal Biochem; 1988 Nov; 174(2):381-92. PubMed ID: 3239743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis.
    Randerath K; Liehr JG; Gladek A; Randerath E
    IARC Sci Publ; 1989; (96):189-205. PubMed ID: 2509347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 32P-postlabelling methods for cyclic DNA adducts.
    Watson WP; Crane AE; Steiner S
    IARC Sci Publ; 1993; (124):255-62. PubMed ID: 8225493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 32P-postlabelling analysis of bulky aromatic adducts.
    Gupta RC
    IARC Sci Publ; 1993; (124):11-23. PubMed ID: 8225473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved reversed-phase high-performance liquid chromatographic separation of 32P-labelled nucleoside 3',5'-bisphosphate adducts of polycyclic aromatic hydrocarbons.
    Pfau W; Phillips DH
    J Chromatogr; 1991 Sep; 570(1):65-76. PubMed ID: 1797837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An improved 32P-postlabelling assay for detection and quantitation of styrene 7,8-oxide-DNA adducts.
    Cantoreggi S; Gupta RC; Lutz WK
    IARC Sci Publ; 1993; (124):201-5. PubMed ID: 8225485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separation of 32P-labelled nucleoside 3',5'-bisphosphate adducts by HPLC.
    Pfau W; Lecoq S; Hughes NC; Seidel A; Platt KL; Grover PL; Phillips DH
    IARC Sci Publ; 1993; (124):233-42. PubMed ID: 8225490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoaffinity concentration of human lung DNA adducts using an anti-benzo[a]pyrene-diol-epoxide-DNA antibody. Analysis by 32P-postlabelling or ELISA.
    King MM; Cuzick J; Jenkins D; Routledge MN; Garner RC
    Mutat Res; 1993 Oct; 292(2):113-22. PubMed ID: 7692247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of DNA adducts formed by aristolochic acids in the target organ (forestomach) of rats by 32P-postlabelling analysis using different chromatographic procedures.
    Stiborová M; Fernando RC; Schmeiser HH; Frei E; Pfau W; Wiessler M
    Carcinogenesis; 1994 Jun; 15(6):1187-92. PubMed ID: 8020154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring occupational exposure to carcinogens: detection by 32P-postlabelling of aromatic DNA adducts in white blood cells from iron foundry workers.
    Phillips DH; Hemminki K; Alhonen A; Hewer A; Grover PL
    Mutat Res; 1988 Mar; 204(3):531-41. PubMed ID: 3347220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and quantitation of hepatic DNA adducts formed in B6C3F1 mice from 1'-hydroxy-2',3'-dehydroestragole: comparison of the adducts detected with the 1'-3H-labelled carcinogen and by 32P-postlabelling.
    Fennell TR; Juhl U; Miller EC; Miller JA
    Carcinogenesis; 1986 Nov; 7(11):1881-7. PubMed ID: 3769137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring carcinogen actions on DNA by 32P-postlabeling.
    Randerath K; Randerath E
    Princess Takamatsu Symp; 1990; 21():317-28. PubMed ID: 2134685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA damage induced by the environmental carcinogen butadiene: identification of a diepoxybutane-adenine adduct and its detection by 32P-postlabelling.
    Leuratti C; Jones NJ; Marafante E; Kostiainen R; Peltonen K; Waters R
    Carcinogenesis; 1994 Sep; 15(9):1903-10. PubMed ID: 7923584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.